XML 22 R7.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES      
Net income $ 1,069,783 $ 867,341 $ 876,914
Adjustments to net income:      
Depreciation and amortization 2,524,200 2,395,644 1,895,177
Amortization of share-based compensation 30,770 57,493 26,227
Non-cash revenue adjustments (121,989) (116,017) (62,029)
Amortization of deferred financing costs 29,652 23,939 26,670
Foreign currency and unrealized derivative loss (gain), net 54,947 (19,394) 37,776
Non-cash interest expense (income) 1,646 11,505 (7,189)
Gain on sales of real estate (177,640) (117,275) (25,667)
Equity in earnings of unconsolidated entities (13,330) (7,793) (2,546)
Distributions on common equity from unconsolidated entities 39,860 21,038 5,807
Provisions for impairment 471,335 425,833 87,082
Deferred income taxes 603 3,552 0
Change in assets and liabilities      
Accounts receivable and other assets (115,792) 28,082 (111,286)
Accounts payable, accrued expenses and other liabilities 193,640 2,607 285,293
Net cash provided by operating activities 3,994,754 3,573,276 2,958,769
CASH FLOWS FROM INVESTING ACTIVITIES      
Investment in real estate (4,647,873) (3,262,437) (8,053,595)
Improvements to real estate, including leasing costs (131,800) (121,411) (68,692)
Investment in unconsolidated entities (52,265) (70,381) (1,179,306)
Investment in loans and preferred equity (1,613,276) (631,650) (201,621)
Proceeds from sales of real estate 744,014 589,450 117,354
Return of investment from unconsolidated entities 0 0 3,927
Proceeds from note receivable 31,390 57,300 0
Insurance proceeds received 3,487 2,788 27,279
Non-refundable escrow deposits 3,150    
Non-refundable escrow deposits   (225) (200)
Net cash acquired in merger 0 93,683 0
Net cash used in investing activities (5,663,173) (3,342,883) (9,354,854)
CASH FLOWS FROM FINANCING ACTIVITIES      
Cash distributions to common stockholders (2,920,895) (2,691,719) (2,111,793)
Cash distributions to preferred stockholders 0 (7,763) 0
Borrowings on revolving credit facilities and commercial paper programs 20,280,426 36,887,003 77,338,040
Payments on revolving credit facilities and commercial paper programs (19,557,427) (36,528,598) (79,398,193)
Proceeds from term loan 406,999 0 1,029,383
Principal payment on term loans (1,139,489) (250,000) 0
Proceeds from notes payable issued 2,891,750 2,657,925 4,239,745
Principal payment on notes payable (1,049,997) (849,999) 0
Principal payments on mortgages payable (44,634) (740,505) (22,015)
Proceeds from common stock offerings, net 2,364,144 1,742,810 5,439,462
Proceeds from dividend reinvestment and stock purchase plan 12,002 11,812 11,519
Redemption of preferred stock 0 (172,510) 0
Distributions to noncontrolling interests (12,024) (10,143) (7,725)
Contributions from noncontrolling interests 488,455 0 0
Net receipts on derivative settlements 0 0 7,853
Debt issuance costs (88,365) (60,615) (81,898)
Other financing activities, net 46,850 (8,856) (7,022)
Net cash provided by (used in) financing activities 1,677,795 (21,158) 6,437,356
Effect of exchange rate changes on cash and cash equivalents 15,874 (5,904) 24,023
Net increase in cash, cash equivalents and restricted cash 25,250 203,331 65,294
Cash, cash equivalents and restricted cash, beginning of period 495,506 292,175 226,881
Cash, cash equivalents and restricted cash, end of period 520,756 495,506 292,175
Mortgages Payable      
Adjustments to net income:      
Amortization of net discounts (premiums) 287 30 (12,803)
CASH FLOWS FROM FINANCING ACTIVITIES      
Principal payments on mortgages payable (44,600)    
Notes Payable      
Adjustments to net income:      
Amortization of net discounts (premiums) $ 6,782 $ (3,309) $ (60,657)